Hjem › Prostatakreft › South Carolina
Kliniske studier for Prostatakreft i South Carolina
42 studier for Prostatakreft søker deltakere på steder i South Carolina.
Byer i South Carolina
- Myrtle Beach23 studier
- Charleston15 studier
- Greenville7 studier
- Spartanburg5 studier
- Greer5 studier
- Florence3 studier
Offisiell studietekst (engelsk)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- Self Regional Healthcare, Greenwood
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- og 12 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Gibbs Cancer Center-Gaffney, Gaffney
- Gibbs Cancer Center-Pelham, Greer
- Spartanburg Medical Center, Spartanburg
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Medical University of South Carolina, Charleston
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Carolina Urologic Research Center, Myrtle Beach
RekruttererObservasjonsstudie
Alder 40 til 75 · Menn · Oppdatert 28. sep. 2026 · NCT07543757Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Myrtle Beach
RekruttererFase 1/2
Alder 18 til 130 · Menn · Oppdatert 25. sep. 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 1/2
Alder 18 og eldre · Menn · Oppdatert 25. sep. 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 25. sep. 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 24. sep. 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Carolinas, Myrtle Beach
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 24. sep. 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 2/3
Alder 18 til 100 · Menn · Oppdatert 22. sep. 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 22. sep. 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- MUSC Hollings Cancer Center, Charleston
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 3
Alder 18 til 100 · Menn · Oppdatert 22. sep. 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Myrtle Beach
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 18. sep. 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT05011383A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- START Carolinas, Myrtle Beach
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 15. sep. 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Lowcountry Urology Clinics, North Charleston
Rekrutterer
Alder 18 og eldre · Menn · Oppdatert 14. sep. 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- McLeod Regional Medical Center, Florence
- Gibbs Cancer Center-Gaffney, Gaffney
- Self Regional Healthcare, Greenwood
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Medical University of South Carolina - Hollings Cancer Center, Charleston
- Prisma Health Cancer Institute, Greenville
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 3. sep. 2026 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 3. sep. 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Myrtle Beach
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 26. aug. 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 25. aug. 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Medical University of South Carolina, Charleston
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 19. aug. 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 17. aug. 2026 · NCT06842498Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Medical University of South Carolina, Charleston
RekruttererFase 1
Alder 18 til 100 · Menn · Oppdatert 13. aug. 2026 · NCT05519449Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 31. jul. 2026 · NCT06613100PSMA PET Combined With MRI for the Detection of PCa
- Atlantic Urology Specialists, Myrtle Beach
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Menn · Oppdatert 23. jul. 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Medical University of South Carolina, Charleston
- Levine Cancer Institute-Rock Hill, Rock Hill
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 9. jul. 2026 · NCT07103018Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 2. jul. 2026 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Ralph H. Johnson VA Medical Center, Charleston
RekruttererObservasjonsstudie
Alder 21 og eldre · Menn · Oppdatert 22. mai 2026 · NCT03151629T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Hollings Cancer Center at Medical University of South Carolina, Charleston
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 4. mar. 2026 · NCT05586360Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
- Medical University of South Carolina Hollings Cancer Center, Charleston
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 5. feb. 2026 · NCT07325721A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
RekruttererFase 1
Alder 18 og eldre · Menn · Oppdatert 4. feb. 2026 · NCT04729114cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881Vitamin D for Prostate Endocrine Therapy
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- og 3 flere
RekruttererFase 3
Alder 50 og eldre · Menn · Oppdatert 15. jan. 2026 · NCT05838716A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 123, Charleston
- Research Site 108, Greenville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. nov. 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.